July 10, 2023
Yuji Kashitani, Chairperson, Regulatory Affairs Committee, JPMA If Japan is to reverse the current trend of drug lags and losses, regulatory authorities should boost development incentives and overseas communications and stop seeking PI Japanese patient data for global products, the...read more